Outlook Therapeutics at 2021 American Society of Retina Specialists (ASRS) Annual Meeting
Safety Results of ONS-5010, an Ophthalmic Bevacizumab, in Treated Eyes of Patients with Wet AMD, DME and BRVO
Presenter: Suber S. Huang, MD, MBA, FASRS
Date and time: October 12, 2021, at 11:08-11:14 AM CDT
For more information and to register for this event, please visit https://www.asrs.org/annual-meeting.